RecruitingNot ApplicableNCT06512064

Acoustic Waveform Respiratory Evaluation

Advancing Telemedicine in Pulmonology: Acoustic-waveform Respiratory Evaluation (AWARE) Via Sensing and Machine Learning on Smartphones


Sponsor

Indiana University

Enrollment

800 participants

Start Date

Jul 23, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The study will evaluate the feasibility of using smartphone speakers and microphones to evaluate the caliber of the airways, detect airway obstruction, aid in airway disease diagnosis, and identify disease exacerbations.


Eligibility

Min Age: 8 YearsMax Age: 70 Years

Inclusion Criteria4

  • Age 8-70 years
  • Ability to perform spirometry and oscillometry
  • Signed informed consent (and assent for children as appropriate)
  • No respiratory or other major disease (for healthy controls), or physician-diagnosed asthma, COPD, CF, or other airway diseases

Exclusion Criteria2

  • Inability or unwillingness to perform AWARE, spirometry, or oscillometry
  • Acute or chronic illness that, at the judgement of investigators, may affect lung function and alter the results of AWARE or the reference PFTs (spirometry and AOS)

Interventions

DIAGNOSTIC_TESTAWARE

AWARE testing to estimate lung function and aid in disease diagnosis


Locations(2)

Indiana University

Indianapolis, Indiana, United States

University of Pittsburgh

Pittsburgh, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06512064


Related Trials